Literature DB >> 33551962

A Novel Scale for Assessment of Stroke Severity at Symptom Onset: Correlation With Neurological Deterioration and Outcome.

Qi Li1, Lan Deng1, Cheng Huang1, Wen-Yu Zhang1,2, Ning Zou1, Du Cao1, Xiao Wei3, Xin-Yue Qin1.   

Abstract

Objective: To propose a novel scale for the assessment of stroke severity at symptom onset and to investigate whether it is associated with ultra-early neurological deterioration (UND) and functional outcomes.
Methods: The Chongqing Stroke Scale (CQSS) was constructed based on key aspects of history, emphasizing language, motor function, and level of consciousness to yield a total 0-11 scale. The diagnostic performance of the CQSS was assessed in 215 ischemic stroke patients between June 2017 and October 2017 in a tertiary hospital. Patients were included if they presented within 24 h after onset of symptoms and they or their witness can recall the scenario at symptom onset. UND was defined as an increase ≥2 points on the CQSS between symptom onset and admission. Functional outcomes were assessed using the 3-month modified Rankin scale. The correlation between the CQSS score and baseline National Institutes of Health Stroke Scale (NIHSS) score was assessed. The sensitivity, specificity, and positive and negative predictive values of CQSS for the outcomes were calculated. Logistic regression was used to test the association between the CQSS score and functional outcomes.
Results: A total of 215 patients with available CQSS scores were included. Baseline CQSS scores at symptom onset were correlated with the admission NIHSS score (r = 0.56, p < 0.001) and functional outcome at 3 months (r = 0.47, p < 0.001). Baseline CQSS ≥ 6 was an independent predictor of functional outcome at 3 months (odds ratio, 12.61; 95% confidence interval 5.68-27.97, p < 0.001). UND was observed in 20 (9.30%) patients. The 90-day mortality was significantly higher in patients with UND than those without UND (25.0 vs. 8.2%, p < 0.001). After adjusting for age, admission systolic blood pressure, hypertension, and diabetes, UND independently predicted poor functional outcome in the multivariate logistic regression model (odds ratio, 9.69; 95% confidence interval 3.19-29.45, p < 0.001). Conclusions: The newly developed CQSS is a simple and easy-to-perform scale that allows a quantitative evaluation of the stroke severity at symptom onset and an assessment of UND before hospital admission. It is associated with NIHSS and predicts functional outcome in patients with acute ischemic stroke.
Copyright © 2021 Li, Deng, Huang, Zhang, Zou, Cao, Wei and Qin.

Entities:  

Keywords:  acute ischemic stroke; functional outcome; prehospital stroke scale; scale; ultraearly neurological deterioration

Year:  2021        PMID: 33551962      PMCID: PMC7862557          DOI: 10.3389/fneur.2020.602839

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  21 in total

1.  Shortening the NIH Stroke scale for use in the prehospital setting.

Authors:  David L Tirschwell; W T Longstreth; Kyra J Becker; Richard E Gammans; LuAnn A Sabounjian; Scott Hamilton; Lewis B Morgenstern
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  Early Neurological Deterioration (END) after stroke: the END depends on the definition.

Authors:  James E Siegler; Sheryl Martin-Schild
Journal:  Int J Stroke       Date:  2011-06       Impact factor: 5.266

3.  Measurements of acute cerebral infarction: a clinical examination scale.

Authors:  T Brott; H P Adams; C P Olinger; J R Marler; W G Barsan; J Biller; J Spilker; R Holleran; R Eberle; V Hertzberg
Journal:  Stroke       Date:  1989-07       Impact factor: 7.914

4.  Cincinnati Prehospital Stroke Scale: reproducibility and validity.

Authors:  R U Kothari; A Pancioli; T Liu; T Brott; J Broderick
Journal:  Ann Emerg Med       Date:  1999-04       Impact factor: 5.721

5.  Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I.

Authors:  A Dávalos; D Toni; F Iweins; E Lesaffre; S Bastianello; J Castillo
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

Review 6.  Clinical interpretation and use of stroke scales.

Authors:  Scott E Kasner
Journal:  Lancet Neurol       Date:  2006-07       Impact factor: 44.182

7.  Early neurological deterioration after thrombolysis: Clinical and imaging predictors.

Authors:  Claus Z Simonsen; Marie L Schmitz; Mette H Madsen; Irene K Mikkelsen; Ronil V Chandra; Thabele Leslie-Mazwi; Grethe Andersen
Journal:  Int J Stroke       Date:  2016-05-17       Impact factor: 5.266

Review 8.  Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications.

Authors:  Pierre Seners; Guillaume Turc; Catherine Oppenheim; Jean-Claude Baron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-06-26       Impact factor: 10.154

9.  The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field.

Authors:  Jennifer N Llanes; Chelsea S Kidwell; Sidney Starkman; Megan C Leary; Marc Eckstein; Jeffrey L Saver
Journal:  Prehosp Emerg Care       Date:  2004 Jan-Mar       Impact factor: 3.077

10.  Design and validation of a clinical scale for prehospital stroke recognition, severity grading and prediction of large vessel occlusion: the shortened NIH Stroke Scale for emergency medical services.

Authors:  Jan Christoph Purrucker; Florian Härtig; Hardy Richter; Andreas Engelbrecht; Johannes Hartmann; Jonas Auer; Christian Hametner; Erik Popp; Peter Arthur Ringleb; Simon Nagel; Sven Poli
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

View more
  1 in total

1.  Levetiracetam Modulates EEG Microstates in Temporal Lobe Epilepsy.

Authors:  Lorenzo Ricci; Pierpaolo Croce; Patrizia Pulitano; Marilisa Boscarino; Filippo Zappasodi; Flavia Narducci; Jacopo Lanzone; Biagio Sancetta; Oriano Mecarelli; Vincenzo Di Lazzaro; Mario Tombini; Giovanni Assenza
Journal:  Brain Topogr       Date:  2022-09-13       Impact factor: 4.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.